FELLOWS

 

Dr. David Berg graduated from Stanford University and earned his medical degree from Harvard Medical School. Dr. Berg completed his internal medicine residency at Brigham and Women’s Hospital, where he served as the chief medical resident. He is currently a senior fellow in cardiovascular medicine and critical care medicine at Brigham and Women’s Hospital and a postdoctoral research fellow with the TIMI Study Group. Dr. Berg’s clinical interests include heart failure, cardiogenic shock, and critical care cardiology. His research is focused on using clinical characteristics, serum biomarkers, and genetic information to optimize treatment of patients with coronary artery disease, heart failure, and other cardiovascular diseases.

Dr. Baris Gencer obtained his medical degree from Lausanne University Hospital in Geneva, Switzerland and continued his residency and fellowship with postgraduate certifications in internal medicine, cardiology and clinical research. He co-authored more than 80 original scientific or review articles, as well as book chapters in the field of lipids, cardiovascular prevention, quality of care, biomarkers and management of acute coronary syndromes. In 2018, he joined Brigham and Women’s Hospital and the TIMI Study Group as a research fellow. His interests include clinical trials and precision medicine in cardiovascular medicine.

Dr. Nicholas Marston graduated summa cum laude from the University of Texas at Austin and earned his medical degree from the University of Minnesota. Dr. Marston completed his internship, residency, and chief medical residency in internal medicine at the University of California San Diego. He is currently in his 3rd year of cardiovascular medicine fellowship at the Brigham and Women’s Hospital, where he is the chief cardiology fellow as well as a research fellow at the TIMI Study Group. His research interests include novel therapeutics in acute coronary syndrome and secondary prevention, genetics of cardiovascular disease, and the application of biomarkers and genetic variants to identify high-risk patients for targeted therapy.

Dr. Kazuma Oyama received his medical degree from Tohoku University, Japan and completed a residency in internal medicine and a fellowship in cardiology at Shonan Kamakura General Hospital. He then received his Ph.D. degree from Tohoku University Graduate School of Medicine. He wrote a Ph.D. thesis regarding perivascular adipose tissue inflammation in patients with coronary artery disease through a translational imaging research. He then engaged in critical care medicine as an assistant professor at Tohoku University Hospital. He is currently a research fellow at the TIMI Study Group and an MPH student at the Harvard School of Public Health. His clinical interests include novel therapeutics in acute coronary syndrome and secondary prevention, genetics for precision medicine and biomarker research.

Dr. Antonio Fagundes Jr. earned his medical degree from the Federal University of Minas Gerais, Brazil, where he completed a residency in internal medicine.  In Sao Paulo, he continued his residency training in cardiology and critical care medicine. He then received his Ph.D. degree from Sao Paulo University (USP). He wrote a Ph.D. thesis studying intra-aortic balloon pump in cardiogenic shock. He then engaged in critical care medicine as an ICU coordinator in Brasilia. He is currently a research fellow at the TIMI Study Group. His clinical interests and research are focused on novel therapeutics in acute coronary syndromes and heart failure, cardiogenic shock, critical care cardiology and biomarker research.